Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India
Read more

Press Release

Sun Pharma and Philogen enter into a global Exclusive Commercialization, License, and Supply Agreement for Commercializing the specialty product FIBROMUN
Read More

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

Subscribe on YouTube

SunPharma on Twitter

Sun Pharma Follow

Official account of world's 4th largest specialty generic pharmaceutical company. See our community guidelines: https://t.co/rYfTm9Nn1i

Avatar
Avatar Sun Pharma @sunpharma_live ·
1 Oct

We have entered into a global licensing agreement with Philogen for commercialising their innovative anti-cancer immunotherapy specialty product, Fibromun.

Read more here: https://bit.ly/3Y4Iwqn

Reply on Twitter 1841027253486157935 Retweet on Twitter 1841027253486157935 5 Like on Twitter 1841027253486157935 45 Twitter 1841027253486157935
Avatar Sun Pharma @sunpharma_live ·
30 Sep

At Sun, sustainability is at the core of who we are. We're proud to be ranked 19th among India’s Top 50 Most Sustainable Companies and 3rd in the ‘Pharma & Healthcare’ sector at @BWBusinessworld's 6th Sustainable World Conclave 2024.

This recognition reaffirms our commitment to…

Reply on Twitter 1840752527253319967 Retweet on Twitter 1840752527253319967 1 Like on Twitter 1840752527253319967 17 Twitter 1840752527253319967
Avatar Sun Pharma @sunpharma_live ·
29 Sep

Recent studies highlight a concerning rise in heart issues among young adults aged 25-49 globally. This World Heart Day, prioritize your well-being with a #HeartToHeartCheck.

Source: Wu P et al, Front Cardiovasc Med. 2023 Nov 24;10:1274663

#WorldHeartDay #WorldHeartDay2024

Reply on Twitter 1840247632297353650 Retweet on Twitter 1840247632297353650 4 Like on Twitter 1840247632297353650 17 Twitter 1840247632297353650
Avatar Sun Pharma @sunpharma_live ·
27 Sep

Big ideas deserve big support! To empower young researchers in India, the Sun Pharma Science Foundation invites applications for its Clinical Research Fellowship 2024.
Selected candidates will have the opportunity to conduct independent clinical research, enabling them to drive…

Reply on Twitter 1839577179396391371 Retweet on Twitter 1839577179396391371 3 Like on Twitter 1839577179396391371 16 Twitter 1839577179396391371
Avatar Sun Pharma @sunpharma_live ·
25 Sep

We are at the upcoming CPHI Milan! Join us there and discover Sun Pharma's comprehensive CRAMS/CDMO solutions.

Our multifaceted contract research and manufacturing services & wide range of APIs can help accelerate your development processes.

To learn more and discuss your…

Reply on Twitter 1838902711955120452 Retweet on Twitter 1838902711955120452 2 Like on Twitter 1838902711955120452 8 Twitter 1838902711955120452
Avatar Sun Pharma @sunpharma_live ·
17 Sep

We’re going to be at CPHI Milan 2024! Know about our extensive API portfolio & global GMP-certified facilities and exchange ideas with us. We’re excited to explore opportunities together.

Register for the event and email [email protected] to schedule a meeting. See you…

Reply on Twitter 1835899233481744734 Retweet on Twitter 1835899233481744734 2 Like on Twitter 1835899233481744734 13 Twitter 1835899233481744734
Avatar Sun Pharma @sunpharma_live ·
13 Sep

‘PACE & Aspire’, our annual conclave celebrates & reinforces our commitment to continuous improvement and operational excellence, recognising our teams’ extraordinary efforts in driving progress across all aspects of our manufacturing operations. Here’s a glimpse of this year’s…

Reply on Twitter 1834569706688115102 Retweet on Twitter 1834569706688115102 2 Like on Twitter 1834569706688115102 15 Twitter 1834569706688115102
Avatar Sun Pharma @sunpharma_live ·
6 Sep

The U.S. Food and Drug Administration has granted Fast Track designation to MM-II (Large Liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain. Planning for confirmatory Phase 3 clinical trials for MM- II is underway.

Read more here: https://bit.ly/4ghnsE8

Reply on Twitter 1832025789937733851 Retweet on Twitter 1832025789937733851 4 Like on Twitter 1832025789937733851 13 Twitter 1832025789937733851
Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Read more

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Read more

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Read more

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Read more
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top